Serum and Urine S100A8 as a New Biomarker of Lupus Nephritis

Bibliographic Information
Authors: Sayed G.K.; Hussein A.M.; Muhammad D.M.; Salah L.; Abdelhadi M.
Journal: Annals of African Medicine
Publisher: Wolters Kluwer Medknow Publications
Publication Date: 24 December 2025
Volume / Issue: Volume 25 / Issue 5
Pages: 1033–1038
ISSN: 15963519
Scopus: View on Scopus
PubMed: 41439532
Document Type: Review
Access: All Open Access; Green Open Access; Hybrid Gold Open Access
Authors and Affiliations
Sayed G.K., Department of Nephrology, Theodor Bilharz Research Institute, Giza, Egypt; Hussein A.M., Department of Nephrology, Faculty of Medicine, Helwan University, Cairo, Egypt; Muhammad D.M., Department of Clinical and Chemical Pathology, Faculty of Medicine, Helwan University, Cairo, Egypt; Salah L., Department of Clinical and Chemical Pathology, Faculty of Medicine, Helwan University, Cairo, Egypt; Abdelhadi M., Department of Internal Medicine, National Research Centre, Giza, Egypt
Abstract
Lupus nephritis (LN) is a common manifestation of systemic lupus erythematosus (SLE) requiring reliable biomarkers for diagnosis and monitoring. This study set out to assess serum and urinary S100A8 as potential biomarkers for LN and investigate their correlation with traditional disease markers. This case-control research comprised 70 participants: 30 LN patients, 20 non-LN SLE patients, and 20 healthy controls. Disease activity was assessed using SLEDAI-2K scores. Serum and urinary S100A8 levels were measured using ELISA. Serum and urinary S100A8 levels were significantly higher in LN patients compared to both non-LN SLE patients and controls (p<0.001). Both markers showed positive correlations with ESR, UPCR, and SLEDAI-2K scores (p<0.05). Serum S100A8 demonstrated 70% sensitivity and 80% specificity at a cutoff >1340 pg/ml (AUC=0.835, p<0.001), while urinary S100A8 showed 83.33% sensitivity and 47.5% specificity at >904 pg/ml (AUC=0.827, p<0.001) for LN diagnosis. Serum and urinary S100A8 levels correlate significantly with LN disease activity and demonstrate promising diagnostic potential. These findings suggest S100A8 could serve as a valuable biomarker for LN diagnosis and monitoring, complementing existing disease markers. © 2025 Annals of African Medicine.
Keywords
Biomarker; lupus nephritis; S100A8; systemic lupus erythematosus; Systemic Lupus Erythematosus Disease Activity Index 2000; calgranulin A; creatinine; adult; case control study; clinical article; controlled study; diagnostic test accuracy study; disease activity; disease marker; enzyme linked immunosorbent assay; erythrocyte sedimentation rate; female; human; lupus erythematosus nephritis; male; predictive value; protein blood level; protein creatinine ratio; protein urine level; receiver operating characteristic; Review; sensitivity and specificity; SLEDAI
Citation Information
Scopus Citations: 1
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
